RI-LINKS2UA - Strengthening Research and Innovation Links towards Ukraine

Follow us

TWINNING ON DNA-BASED CANCER VACCINES

Project

  • VACTRAIN
  • Posted on: Oct 11, 2016

Post Date: Oct 11, 2016

Tags: Horizon 2020, Policy support, Tools, SME

The objective of this Twinning project is to significantly strengthen the research in Riga Stradins University (RSU; Latvia) in the smart specialization area of Latvia “bio-medicine, medical technologies, and biotechnologies” with application to immunotherapy of cancer through building an up-rising connections with two internationally leading research institutions, Institute of Microbiology, Tumor and Cell Biology, Karolinska Institutet (Sweden) and the Department of General Biophysics, University of Lodz (Poland). Both represent centers of excellence in the design, testing and clinical applications of a wide class of immunotherapeuticals, with focus on technologies exploiting naked nucleic acids.

Call ID: H2020-TWINN-2015
Overall EC contribution: € 999,475.00
Name of UA partner(s) involved:

R.E Kavetsky Institute of Experimental Pathology Oncology and Radiobiology of National Academy of Sciences of Ukraine

Share on